GlaxoSmithKline plc ADR

Historical 13F Holders

Symbol
GSK
CUSIP
37733W105
All holders as of
Q1 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 6 825 k $31.9 M
2024 Q4 6 887 k $30.0 M
2024 Q3 7 1.09 M $44.4 M
2024 Q2 7 1.27 M $48.9 M
2024 Q1 9 1.28 M $54.9 M
2023 Q4 8 1.27 M $47.1 M
2023 Q3 9 1.30 M $47.0 M
2023 Q2 9 1.29 M $45.5 M
2023 Q1 9 1.29 M $45.9 M
2022 Q4 13 1.31 M $46.4 M
2022 Q3 36 2.70 M $79.8 M
2022 Q2 877 339 M $15.6 B
2022 Q1 972 333 M $14.5 B
2021 Q4 966 328 M $14.5 B
2021 Q3 826 324 M $12.4 B
2021 Q2 831 320 M $12.7 B
2021 Q1 809 317 M $11.3 B
2020 Q4 866 306 M $11.3 B
2020 Q3 863 299 M $11.2 B
2020 Q2 880 306 M $12.5 B
2020 Q1 854 314 M $11.9 B
2019 Q4 934 297 M $13.9 B
2019 Q3 842 283 M $12.1 B
2019 Q2 851 286 M $11.5 B
2019 Q1 887 281 M $11.7 B
2018 Q4 834 276 M $10.5 B
2018 Q3 824 275 M $11.0 B
2018 Q2 829 277 M $11.1 B
2018 Q1 820 276 M $10.8 B
2017 Q4 802 273 M $9.69 B
2017 Q3 775 243 M $9.85 B
2017 Q2 815 230 M $9.90 B
2017 Q1 826 225 M $9.51 B
2016 Q4 807 214 M $8.23 B
2016 Q3 780 207 M $8.93 B
2016 Q2 784 215 M $9.52 B
2016 Q1 762 205 M $8.35 B
2015 Q4 770 217 M $8.80 B
2015 Q3 749 219 M $8.42 B
2015 Q2 769 235 M $9.75 B
2015 Q1 778 251 M $11.7 B
2014 Q4 780 255 M $21.1 B
2014 Q3 743 265 M $12.3 B
2014 Q2 754 286 M $15.4 B
2014 Q1 746 262 M $14.1 B